Skip to main content
. 2022 Aug 3;14(15):3782. doi: 10.3390/cancers14153782
BC Bladder cancer
NB Normal bladder
N Normal
T Tumor
TCGA The Cancer Genome Atlas;
OS Overall survival
DSS Disease Specific Survival
PFI Progression Free Interval
CR Complete Response;
PR Partial Response;
SD Stable Disease;
PD Progressive Disease;
GSEA Gene Set Enrichment Analysis;
KM analysis Kaplan-Meier analysis;
GEM Gemcitabine;
T24-GEM-R Gemcitabine resistant T24;
5637GEM-R Gemcitabine resistant 5637
IC50 Half maximal inhibitory concentration.
ROS Reactive oxygen species